Maas_Psychedelica
Greenlighter
- Joined
- Jun 22, 2020
- Messages
- 1
We are researchers at Maastricht University, and are about to start a range of experimental trials with novel psychoactive drugs (NPS); psychedelic compounds often labelled as research chemicals which have yet been tested in man. Some of these, despite their considerable age and popularity (such as the archetypal Shulgin family of 2C-X compounds or the many flavours of tryptamine analogues) are sparsely documented.
So, as the scientific literature is lacking, we would like to learn as much as possible from the NPS using community, and are looking for people to tell us more about some of these substances! By providing us with key information regarding motivations for use, demographics, subjective effect profiles and dosing parameters, you would help inform new ventures for clinical research and provide groundwork for harm-reduction initiatives.
As always, any/all information you give us is entirely anonymous and will be published in a publicly available, scientific peer-reviewed journal (you can find here here an example of our previous work).
This survey is expected to run until December 2020 and has been approved by the Ethical Committee of Psychology and Neuroscience (ERCPN), Maastricht University, Netherlands.
If you would like to know more about us, you can stay up to date with twitter. If any questions arise, do contact us through Bluelight or via one of our study coordinators:
[email protected]
[email protected]
Thank you for your help!
So, as the scientific literature is lacking, we would like to learn as much as possible from the NPS using community, and are looking for people to tell us more about some of these substances! By providing us with key information regarding motivations for use, demographics, subjective effect profiles and dosing parameters, you would help inform new ventures for clinical research and provide groundwork for harm-reduction initiatives.
If you are at least 18 years of age and have a spare 15 minutes, please follow the link below for more information:
Experiences with NPS
Experiences with NPS
As always, any/all information you give us is entirely anonymous and will be published in a publicly available, scientific peer-reviewed journal (you can find here here an example of our previous work).
This survey is expected to run until December 2020 and has been approved by the Ethical Committee of Psychology and Neuroscience (ERCPN), Maastricht University, Netherlands.
If you would like to know more about us, you can stay up to date with twitter. If any questions arise, do contact us through Bluelight or via one of our study coordinators:
[email protected]
[email protected]
Thank you for your help!